15 November, 2021 by The TZ Newswire Staff Comments Off on BOUYGUES : RÉSULTATS DES NEUF PREMIERS MOIS 2021
BOUYGUES : RÉSULTATS DES NEUF PREMIERS MOIS 2021
COMMUNIQUÉ DE PRESSE
15 November, 2021 by The TZ Newswire Staff Comments Off on BOUYGUES: NINE-MONTH 2021 RESULTS
BOUYGUES: NINE-MONTH 2021 RESULTS
PRESS RELEASE
15 November, 2021 by The TZ Newswire Staff Comments Off on Finantskalender 2022. aastal
Finantskalender 2022. aastal
2022. aastal avaldab AS Ekspress Grupp konsolideeritud majandustulemused ja kvartaalsed digitellimuste tulemused järgmiselt.
15 November, 2021 by The TZ Newswire Staff Comments Off on Financial reporting calendar for year 2022
Financial reporting calendar for year 2022
In 2022 AS Ekspress Grupp will publish its consolidated financial results and quarterly results of digital subscriptions according to the schedule below.
15 November, 2021 by The TZ Newswire Staff Comments Off on BGHL (EUR): NAV(s)
BGHL (EUR): NAV(s)
BOUSSARD & GAVAUDAN HOLDING LIMITED
15 November, 2021 by The TZ Newswire Staff Comments Off on Sampo Oyj:n omien osakkeiden ostot 15.11.2021
Sampo Oyj:n omien osakkeiden ostot 15.11.2021
SAMPO OYJ PÖRSSITIEDOTE 16.11.2021 klo 08:30
15 November, 2021 by The TZ Newswire Staff Comments Off on OSE Immunotherapeutics Presented New Translational Data on Tedopi® and Preclinical Data on PD-1/IL-7 Bifunctional Program BiCKI®-IL-7
OSE Immunotherapeutics Presented New Translational Data on Tedopi® and Preclinical Data on PD-1/IL-7 Bifunctional Program BiCKI®-IL-7
Data presented at the 36th Annual Society for Immunotherapy of Cancer (SITC) Meeting Data presented at the 36th Annual Society for Immunotherapy of Cancer (SITC) Meeting